Table 1. Correlation between miR-148a levels and clinico-pathological characteristics in human primary HCC specimens.
miR-148a expression | |||
---|---|---|---|
low (n=30) | high (n=29) | p-value | |
Age Mean ± SD |
52.8±10.05 |
56.1±11.02 |
0.4701 |
Gender Male Female |
24 6 |
18 11 |
0.1282 |
Tumor size (cm) ≤5 >5 |
16 14 |
19 10 |
0.3412 |
Tumor stage* TNM I TNM II-III |
10 20 |
24 5 |
<0.001**2 |
Vascular invasion No Yes |
13 17 |
27 2 |
<0.001**3 |
Satellite nodule No Yes |
27 3 |
27 2 |
0.6693 |
E-S grade (MC) I-II III- IV |
20 10 |
24 5 |
0.1562 |
AFP (ng/ml) ≤20 >20 |
7 23 |
18 11 |
0.003**2 |
Etiology HBV HCV Alcohol Idiopathic |
25 1 1 3 |
22 2 2 3 |
0.7593 |
modified AJCC
p<0.01,
1Student's t- test,
2Chi-square test,
3Fisher's exact test
Abbreviation: AFP, α-fetoprotein; AJCC, American Joint Committee on Cancer; HBV, hepatitis B virus;